DALLAS, September 5, 2014 /PRNewswire/ --
This immunoassay automation market report summarizes the results of an industry-wide global web-based benchmarking survey on immunoassays and their automation carried out in August 2014. The survey, now available with ReportsnReports.com at http://www.reportsnreports.com/reports/297405-immunoassay-automation-trends-2014.html, looked at the following aspects of immunoassays, as practiced today (2014) and in many cases as predicted for the future (2017): main use of immunoassay technology today; main application area of immunoassay research; target classes investigated by immunoassays; main sample sources analyzed; enzyme/detection chemistry most used; level of automation applied; capital cost of automated solutions implemented; brief details of automated solution implemented; level of automation respondents want to achieve; how respondents prefer to access immunoassay automation; plans to purchase an automated immunoassay workstation and preferred automation vendors; factors influencing a decision to select a vendor for immunoassay automation; maximum capital cost for an automated (hands free) immunoassay workstation; awareness of new emerging immunoassay platforms or alternatives technologies; main drivers for adopting a new automated immunoassay platform; barriers to change that would limit adoption of a new automated immunoassay platform; enthusiasm to change assay buffers and/or protocols to work with a new automated immunoassay platform; number of immunoassay plates typically run per year; maximum immunoassay throughput achieved and wanted; assay formats used for immunoassay analysis; final immunoassay (incubation) volume; number of different immunoassays developed (self-built) per year; average cost per single immunoassay (per well); price paid for immunoassay kits and application area pricing relates to; annual budget for immunoassay consumables and the breakdown of that budget into components; most important factors in the decision to purchase a particular vendor's immunoassay kit; main suppliers of immunoassay kits purchased; biggest hurdles (limitations) that still need to be addressed with immunoassays today; and any unmet needs that exist in immunoassay automation today.
Some of the highlights from the Immunoassay Automation Trends 2014 survey include:
> Only 14% of respondents had applied full automation to their immunoassays to date.
> The median capital cost of immunoassay automation already implemented to date was $40K-$60K.
> The level of automation implemented is tabulated versus the capital cost paid for that automation.
> Brief details of the immunoassay automation solutions respondents have already implemented were listed.
> Most respondents want to achieve in the future full workflow (walkaway) immunoassay automation on an open generic platform.
> The median interest in acquiring a fully automated immunoassay workstation over the coming years was possible (26-50% probability), with Bio-Rad and Tecan currently the most preferred automation vendors.
> Precision was rated the greatest impact on a decision to select an immunoassay automation vendor.
> The median maximum price respondents would pay for an automated system that could run their immunoassay requirements hands free was $60K.
> Of a list of new emerging automated immunoassays platforms or alternative technologies respondents were most aware of Luminex microparticle-based flow tests; PerkinElmer AlphaLISA; qPCR-based alternative tests; and MesoScale Discovery ECL multiarray technology.
> Facilitates improved performance/greater sensitivity/better uniformity was ranked the main motivator/driver for adopting a new improved or automated immunoassay platform.
> The requirement to invest in new capital equipment was rated the most important barrier to change that would limit the adoption of a new improved or automated immunoassay platform.
> The majority of respondents were amenable to changing assay buffers and/or protocols to work with a new immunoassay platform with potential to significantly improve performance.
> The median number of 96-well immunoassay plates run per year was 100.
> The median maximum immunoassay throughput achieved was five 96-well plates per 8h day.
> The majority of immunoassay samples were analyzed in or from a 96-well microplate format today.
> The median final assay volume for immunoassays assays today was 50μL to 100μL.
> 67% of respondents reported that they develop (self-build) immunoassays.
> A median of 3 new immunoassays were developed per year.
> The median cost per single immunoassay (well) today was $1-$2.50.
> $300-$400 was the median average price paid per immunoassay kit of 96-wells.
> $400-$500 was the median maximum price respondents would want to pay for an immunoassay kit of 96-wells.
> The cost paid per immunoassay kit was tabulated with the application area of the kits priced.
> The median annual immunoassay consumables budget per lab per year today was $25K-$50K.
> The greatest proportion of the immunoassay consumables budget was spent on immunoassay kits (single analyte assays), followed by antibodies and then immunoassays kits (multiplexed assays).
> A bottom-up model was developed around the respondent's annual budget for immunoassay consumables to estimate the global market, which in 2014 was around $900M. Nearly 50% of this market was allocated to immunoassays kits (both single and multiplexed analytes). The market was segmented by immunoassay activity focus and geography, with CAGR estimates for 2017 made.
> Specificity (i.e. cross-reactivity & interference with related analytes) was rated as the factor of greatest importance in a decision to purchase a supplier's immunoassay kit.
> The main (most used) supplier of immunoassay kits purchased by respondents was R&D Systems.
> Improving detection capability in complex samples was ranked the biggest hurdle (limitation) with immunoassays today.
> Feedback on some unmet needs that exist in immunoassay automation today were listed.
> The full report provides the data, details of the breakdown of the responses for each question, its segmentation and some estimates for the future (2017). It also highlights some interesting differences between the survey groups.
PLEASE NOTE: This Immunoassay Automation Trends 2014 market report covers all types of immunoassays, it includes conventional ELISAs, immunoassays that are linked to some non-enzymatic reporters or are homogenous (no-wash) (e.g. PerkinElmer AlphaLISA) and those microparticle-based methods (e.g. Luminex, BioScale, Gyros) that remove samples from microplates for analysis and utilize flow-based detection.
Order a copy of Immunoassay Automation Trends 2014 market research report at http://www.reportsnreports.com/Purchase.aspx?name=297405 .
Explore more reports on biotechnology market and general healthcare industry at http://www.reportsnreports.com/market-research/healthcare/ .
ReportsnReports.com is an online market research reports library of 450,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.
Connect With Us on:
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252